We have located links that may give you full text access.
Traceability of immunosuppressant's mass concentration results obtained using different commercial calibrators.
Clinical Biochemistry 2018 October 4
BACKGROUND: Due to the high inter-variability in immunosuppressants pharmacokinetics, therapeutic drug monitoring of these drugs is essential in order to minimize the risk of rejection after organ transplantation. Thus, results facilitated to clinicians by clinical laboratories for these drugs should be as reliable as possible. The knowledge of metrological traceability and performing compatibility studies can allow ensuring reliability of these results, mainly, when laboratories introduce substantial changes in their measurement procedures, e.g., when they change the calibration materials. The aim of this study was to investigate, as an example, the traceability of the calibrator's assigned values from two manufacturers (Recipe and Chromsystems) and to perform compatibility studies for sirolimus and tacrolimus.
MATERIAL AND METHODS: Traceability was described according to ISO 17511. Compatibility studies, based on the CLSI EP029-A guideline, were performed verifying the trueness processing the ERM®-DA111a and ERM®-DA110a reference materials.
RESULTS: Traceability studies reveled that sirolimus and tacrolimus results were traceable to SI, except for sirolimus if Chromsystems' calibrators was used. Using Recipe's calibrators, the absolute relative biases and their expanded uncertainties were 1.23% and ±6.10% for sirolimus, and 1.41% and ±3.02% for tacrolimus. Furthermore, when Chromsystems' calibrators were used, these values were 12.2% and ±6.02% for sirolimus, and 2.64% and ±2.94% for tacrolimus.
CONCLUSIONS: Results reported a lack of traceability and compatibility of sirolimus' results when Chromsystems' calibrators was used. In order to avoid it, laboratories should only use calibrators with assigned values traceable to highest reference materials or, alternatively, perform a compatibility study and apply a bias correction factor.
MATERIAL AND METHODS: Traceability was described according to ISO 17511. Compatibility studies, based on the CLSI EP029-A guideline, were performed verifying the trueness processing the ERM®-DA111a and ERM®-DA110a reference materials.
RESULTS: Traceability studies reveled that sirolimus and tacrolimus results were traceable to SI, except for sirolimus if Chromsystems' calibrators was used. Using Recipe's calibrators, the absolute relative biases and their expanded uncertainties were 1.23% and ±6.10% for sirolimus, and 1.41% and ±3.02% for tacrolimus. Furthermore, when Chromsystems' calibrators were used, these values were 12.2% and ±6.02% for sirolimus, and 2.64% and ±2.94% for tacrolimus.
CONCLUSIONS: Results reported a lack of traceability and compatibility of sirolimus' results when Chromsystems' calibrators was used. In order to avoid it, laboratories should only use calibrators with assigned values traceable to highest reference materials or, alternatively, perform a compatibility study and apply a bias correction factor.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app